Cargando…
Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine
Autores principales: | Sissa, Cinzia, Al-Khaffaf, Ahmad, Frattini, Francesco, Gaiardoni, Roberta, Mimiola, Elda, Montorsi, Paolo, Melara, Barbara, Amato, Massimo, Peyvandi, Flora, Franchini, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051010/ https://www.ncbi.nlm.nih.gov/pubmed/33888416 http://dx.doi.org/10.1016/j.transci.2021.103145 |
Ejemplares similares
-
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023) -
Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19
por: Capecchi, Marco, et al.
Publicado: (2020) -
Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018) -
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
por: Capecchi, Marco, et al.
Publicado: (2023) -
Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study
por: Ferrari, Barbara, et al.
Publicado: (2014)